2.035
Precedente Chiudi:
$2.02
Aprire:
$2.02
Volume 24 ore:
7,327
Relative Volume:
0.07
Capitalizzazione di mercato:
$95.20M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.35%
1M Prestazione:
+2.26%
6M Prestazione:
+24.09%
1 anno Prestazione:
+0.00%
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Nome
Whitehawk Therapeutics Inc
Settore
Industria
Telefono
551-321-2234
Indirizzo
2 HEADQUARTERS PLAZA, MORRISTOWN
Confronta WHWK con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
WHWK
Whitehawk Therapeutics Inc
|
2.02 | 95.20M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.65 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-08-21 | Downgrade | Jefferies | Buy → Hold |
2024-08-21 | Downgrade | TD Cowen | Buy → Hold |
2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
2022-01-11 | Iniziato | Jefferies | Buy |
2021-10-01 | Iniziato | Cowen | Outperform |
2021-09-14 | Iniziato | Ladenburg Thalmann | Buy |
2021-09-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Whitehawk Therapeutics Inc Borsa (WHWK) Ultime notizie
How to integrate Whitehawk Therapeutics Inc. into portfolio analysis toolsJuly 2025 Sentiment & Fast Gain Swing Alerts - newser.com
Can Whitehawk Therapeutics Inc. stock sustain institutional interestQuarterly Trade Report & Precise Buy Zone Tips - newser.com
What to expect from Whitehawk Therapeutics Inc. in the next 30 daysJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Will a bounce in Whitehawk Therapeutics Inc. offer an exitStock Surge & AI Driven Price Predictions - newser.com
Key resistance and support levels for Whitehawk Therapeutics Inc.Price Action & Advanced Swing Trade Entry Plans - newser.com
What Fibonacci levels say about Whitehawk Therapeutics Inc. reboundProduct Launch & Daily Profit Maximizing Tips - newser.com
Whitehawk Therapeutics (NASDAQ:WHWK) Raised to Hold at Zacks Research - MarketBeat
Quantitative breakdown of Whitehawk Therapeutics Inc. recent moveOptions Play & Low Volatility Stock Recommendations - newser.com
Is Whitehawk Therapeutics Inc. reversing from oversold territoryCEO Change & Safe Capital Preservation Plans - newser.com
How analysts rate Whitehawk Therapeutics Inc. stock todayQuarterly Growth Report & Long-Term Capital Growth Ideas - newser.com
Is Whitehawk Therapeutics Inc. showing signs of accumulationJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Comparing Whitehawk Therapeutics Inc. in custom built stock radars2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Whitehawk Therapeutics' (WHWK) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Whitehawk Therapeutics, Inc.'s (NASDAQ:WHWK) large hedge funds owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st
Is Whitehawk Therapeutics Inc. stock safe for conservative investors2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
How to read the order book for Whitehawk Therapeutics Inc.2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Whitehawk Therapeutics Inc. (3350) stock attracts HNW investors2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
Will Whitehawk Therapeutics Inc. (3350) stock outperform small cap peersAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Why Whitehawk Therapeutics Inc. stock is trending among retail traders2025 Dividend Review & Smart Allocation Stock Tips - newser.com
Using economic indicators to assess Whitehawk Therapeutics Inc. potentialTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Is Whitehawk Therapeutics Inc. forming a reversal patternJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is Whitehawk Therapeutics Inc. (3350) stock positioned for secular growthJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Analyzing Whitehawk Therapeutics Inc. with risk reward ratio chartsJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Whitehawk Therapeutics Inc Stock Analysis and ForecastLow Risk Investment Ideas & Exceptional Capital Trading - earlytimes.in
Whitehawk Therapeutics Inc Azioni (WHWK) Dati Finanziari
Non sono disponibili dati finanziari per Whitehawk Therapeutics Inc (WHWK). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Whitehawk Therapeutics Inc Azioni (WHWK) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Giacobello Scott M. | CHIEF FINANCIAL OFFICER |
Mar 03 '25 |
Sale |
2.35 |
2,806 |
6,594 |
23,944 |
Lennon David James | CHIEF EXECUTIVE OFFICER |
Mar 03 '25 |
Sale |
2.35 |
5,690 |
13,372 |
33,429 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):